NorthEast BioLab Logo | Advanced Bioanalytical Services Lab Agile Bioanalytical Services CRO
  • Expertise
    • Menu IconAll Expertise
    • Menu IconMass Spectrometry (LC-MS)
      • Menu IconMass Spectrometry Services
      • Menu IconHPLC Testing Services
    • Menu IconMeso Scale Discovery Assay
    • Menu IconELISA Assay
      • Menu IconLuminex Multiplex Assay
    • Menu IconFlow Cytometry
    • Menu IconqPCR Analysis, ddPCR Assay
    • Menu IconWestern Blot, In Cell Western
  • Services
    • Menu IconAll Services
    • Menu IconPharmacokinetics (PK) Study
      • Menu IconToxicology (Tox) Study
      • Menu IconDose Formulation Analysis
      • Menu IconPK PD Analysis
      • Menu IconDrug Metabolism and Pharmacokinetics (DMPK)
      • Menu IconADME Studies
      • Menu IconBioequivalence and Bioavailability Studies
    • Menu IconADA Assay, Neutralizing Antibody Assay
    • Menu IconMultiplex Cytokine Assay
    • Menu IconBiomarker Assay
      • Menu IconBiomarker Assay List
    • Menu IconCell-Based Assay
      • Menu IconMechanism of Action (MOA) Studies
      • Menu IconCytotoxicity Assay
      • Menu IconBiochemical Assay
    • Menu IconBioanalytical Assay Validation
  • Solutions
    • Menu IconAll Solutions
    • Menu IconClinical CRO
      • Menu IconCentral Lab Services
      • Menu IconPBMC Services
    • Menu IconGLP Laboratory
      • Menu IconBioanalysis
      • Menu IconNon-GLP Testing
    • Menu IconPreclinical CRO
    • Menu IconMethod Development, Validation, And Transfer
      • Menu IconMethod Validation
      • Menu IconMethod Development
      • Menu IconMethod Transfer
    • Menu IconAnalytical Testing
      • Menu IconDiscovery Screening Services
      • Menu IconAnalytical Quantitation
      • Menu IconCosmetic Testing
  • About Us
    • Menu IconAbout Us
    • Menu IconOverview
    • Menu IconLeadership
    • Menu IconFacility and Equipment
    • Menu IconQuality and Compliance
    • Menu IconTherapeutic Areas
    • Menu IconWhy Us?
    • Menu IconValues
    • Menu IconProcess
    • Menu IconPartners
    • Menu IconCareers
      • Business Development Associate
      • Sr. Scientist – Cell Based Assay
      • GLP Quality Assurance Manager
      • Sr. Scientist, ELISA Immunoassay Bioanalysis
      • Sr. Scientist, LC-MS/MS Bioanalysis
      • Associate Scientist, Central Laboratory Services
      • Sr. Scientist - Pharmacokinetics (PK)
      • Content Manager, Scientific and Regulatory Writing
  • Resources
    • Menu IconLearning Center
    • Menu IconBlog
    • Menu IconCase Study
    • Menu IconVideo Brochures
    • Menu IconNews and Events
    • Menu IconTestimonials
    • Menu IconContact Us
  • Request Quote
NorthEast BioLab Logo | Advanced Bioanalytical Services Lab Agile Bioanalytical Services CRO Request Quote

Expertise

  • Menu IconAll Expertise
    • Menu IconMass Spectrometry (LC-MS)
      • Menu IconMass Spectrometry Services
      • Menu IconHPLC Testing Services
    • Menu IconMeso Scale Discovery Assay
      • Menu IconELISA Assay
        • Menu IconLuminex Multiplex Assay
      • Menu IconFlow Cytometry
        • Menu IconqPCR Analysis, ddPCR Assay
          • Menu IconWestern Blot, In Cell Western

            Services

            • Menu IconAll Services
              • Menu IconPharmacokinetics (PK) Study
                • Menu IconToxicology (Tox) Study
                • Menu IconDose Formulation Analysis
                • Menu IconPK PD Analysis
                • Menu IconDrug Metabolism and Pharmacokinetics (DMPK)
                • Menu IconADME Studies
                • Menu IconBioequivalence and Bioavailability Studies
              • Menu IconADA Assay, Neutralizing Antibody Assay
                • Menu IconMultiplex Cytokine Assay
                  • Menu IconBiomarker Assay
                    • Menu IconBiomarker Assay List
                  • Menu IconCell-Based Assay
                    • Menu IconMechanism of Action (MOA) Studies
                    • Menu IconCytotoxicity Assay
                    • Menu IconBiochemical Assay
                  • Menu IconBioanalytical Assay Validation

                    Solutions

                    • Menu IconAll Solutions
                      • Menu IconClinical CRO
                        • Menu IconCentral Lab Services
                        • Menu IconPBMC Services
                      • Menu IconGLP Laboratory
                        • Menu IconBioanalysis
                        • Menu IconNon-GLP Testing
                      • Menu IconPreclinical CRO
                        • Menu IconMethod Development, Validation, And Transfer
                          • Menu IconMethod Validation
                          • Menu IconMethod Development
                          • Menu IconMethod Transfer
                        • Menu IconAnalytical Testing
                          • Menu IconDiscovery Screening Services
                          • Menu IconAnalytical Quantitation
                          • Menu IconCosmetic Testing

                        About Us

                        • Menu IconAbout Us
                          • Menu IconOverview
                            • Menu IconLeadership
                              • Menu IconFacility and Equipment
                                • Menu IconQuality and Compliance
                                  • Menu IconTherapeutic Areas
                                    • Menu IconWhy Us?
                                      • Menu IconValues
                                        • Menu IconProcess
                                          • Menu IconPartners
                                            • Menu IconCareers
                                              • Menu IconBusiness Development Associate
                                              • Menu IconSr. Scientist – Cell Based Assay
                                              • Menu IconGLP Quality Assurance Manager
                                              • Menu IconSr. Scientist, ELISA Immunoassay Bioanalysis
                                              • Menu IconSr. Scientist, LC-MS/MS Bioanalysis
                                              • Menu IconAssociate Scientist, Central Laboratory Services
                                              • Menu IconSr. Scientist - Pharmacokinetics (PK)
                                              • Menu IconContent Manager, Scientific and Regulatory Writing

                                            Resources

                                            • Menu IconLearning Center
                                              • Menu IconBlog
                                                • Menu IconCase Study
                                                  • Menu IconVideo Brochures
                                                    • Menu IconNews and Events
                                                      • Menu IconTestimonials
                                                        • Menu IconContact Us

                                                          Request Quote

                                                            Contact Us

                                                            • Home
                                                            • PK Assay, Pharmacokinetics Services, Pharmacokinetics Study, PK CRO

                                                            Reliable Pharmacokinetics Services CRO And PK Assay Lab Trusted By Biotech Pioneers Over 20+ Years!

                                                            Contact Us With PK Assay Or Pharmacokinetics Study Details

                                                            We Will Respond Within 1 Business Day

                                                            • High-Value, Pharmacokinetics Study For Your Therpeutics And Metabolite(s)
                                                            • FDA Audited PK Assay Services CRO To De-Risk Your Small Molecule, Biologics, Cell And Gene Therapy
                                                            • SAD MAD Clinical Pharmacokinetics Services At Industry-Leading Turnaround
                                                            • GLP Pharmacokinetics CRO Services On LC-MS, ELISA, Meso Scale, qPCR, Etc.

                                                            Regulated And Inspected By:

                                                            Good Laboratory Practice for Nonclinical Laboratory Studies | NorthEast BioLab Food and Drug Administration (FDA | NorthEast BioLab Clinical Laboratory Improvement Amendments | NorthEast BioLab International Orgaization for Standardization |NorthEast BioLab
                                                            + Years Of Bioanalysis
                                                            + Small/Large Molecule Studies
                                                            + Custom Bioanalytical Assays
                                                            + Investigational Drugs
                                                            + Biomarker & Cytokine Assays

                                                            What PK Assay and Pharmacokinetics CRO Services Do We Offer?

                                                            Comprehensive PK CRO and sample analysis services to assess drug exposure and therapeutic potential from development to clinical trials.

                                                            PK Assay Development, Optimization, or Method Transfer

                                                            • Design and optimize PK Assay using Column Chromatography (LC-MS/MS or HPLC-UV/DAD) Method Development
                                                            • Ligand-binding (Direct, Indirect, Sandwich, Competitive) PK ELISA Assay, Mesoscale Discovery, Or Hybrid Assay for Biologics, Proteins, Oligonucleotides, etc

                                                            Pharmacokinetics Assay Validation Services

                                                            • Fit-for-purpose (FFP) as per FDA Bioanalytical Method Validation Guidance (GLP, GCLP) in the Context-of-Use (COU)
                                                            • Suitable calibration range for any given PK sample collection, preparation, and storage limitations

                                                            Pharmacokinetic (PK) Assessment For Safety and Efficacy

                                                            • GLP Pharmacokinetic studies in rodents and large animals as well as analysis of PK samples in PK clinical trial
                                                            • ADME, biodistribution, and bioavailability evaluation in multiple matrices including plasma/serum, urine, CSF, stool, cell lysates, and tissue homogenates

                                                            PK analysis using Certara's WinNonlin™ for clinical trial samples.

                                                            • PK CRO services to determine clearance (Cl/F), the volume of distribution (Vz/F), maximum concentration (Cmax), time of maximum concentration (Tmax), elimination half-life (t1/2), the area under the curve (AUC), Lambda Z, and other relevant PK parameters for PK samples in clinical trials
                                                            • PK and PD analysis for further development and validation of Pharmacodynamic activity, immunogenicity (ADA), and neutralizing antibody (nAb) Assays

                                                            Preclinical and clinical PK lab support for trial samples.

                                                            • Preclinical pharmacology, enzyme induction/inhibition, metabolic stability, protein binding, DMPK, Or ADME Lab and research services
                                                            • Exposure, half-life, clearance, and drug tolerance input for Pharmacodynamic Or
                                                              immunogenicity (ADA)

                                                            Stability Testing Pharmacokinetics Lab Services

                                                            • Qualify PK Sample analysis following long-term storage
                                                            • PK Assay set-up and test run(s) for stock solutions, calibration curve, and quality controls

                                                            Our Veteran Scientists Have Deep And Diverse Expertise In Clinical Pharmacokinetics Service To Deliver High-Quality Results!

                                                            Benefit icon

                                                            Small Molecule, Metabolite PK

                                                            Rapid, Regulatory-Compliant SAD/MAD Method Validation Plus Clinical Quantitation In Plasma, Urine, And CSF

                                                            Benefit icon

                                                            Monoclonal Ab PK ELISA

                                                            ELISA Development, GLP Validation, and Sample Analysis in Rat, Rabbit, Minipig, Dog, Human Serum

                                                            Benefit icon

                                                            Antibody Drug Conjugate PK

                                                            ELISA/MSD Total Antibody, Conjugated Antibody Assay Plus Mass Spec Payload Assay In Rat, NHP, Or Human Matrices

                                                            Benefit icon

                                                            Antisense Oligo (ASO) PK

                                                            Oligonucleotide LC MS Method Development And Qualification In Rat And NHP Tissue

                                                            Benefit icon

                                                            Bispecifc Ab, Trispecific PK

                                                            ELISA/MSD Assay Development, GLP Validation for Specific Domains Plus Free vs. Bound In Rat, NHP, Or Human Matrices

                                                            Benefit icon

                                                            Humanized FAb PK ELISA

                                                            Assay Development, GLP Validation, and Sample Analysis in NHP Plasma (and nGLP Ocular Tissues)

                                                            Benefit icon

                                                            Peptide Plus Payload PK

                                                            PK LC-MS/MS Method Development and Validation in Rat, NHP, and Human Plasma

                                                            Benefit icon

                                                            Oligo PK Hybrid ELISA

                                                            MSD Assay Development, GLP Validation, Sample Analysis in SD Rat, DB+NZ Rabbit, Human Plasma+Urine

                                                            Contact A Scientist With Your Pharmacokinetic Study Details

                                                            We Will Respond Within 1 Business Day

                                                            forms-banner
                                                            Instrument Image

                                                            One-stop Bioanalytical Lab For PK LC-MS and PK ELISA Assay Services CRO To Exceed Your Expectations in Pharmacokinetics Clinical Trials.

                                                            Contact A Scientist With Your Pharmacokinetic Study Details

                                                            We Will Respond Within 1 Business Day

                                                            • Detailed PK assay analysis to identify and resolve hidden issues that could delay drug development.
                                                            • Highly responsive and flexible PK lab to accelerate your drug development process.
                                                            • Expert PK sample analysis to support regulatory submissions without exceeding your budget.

                                                            20+

                                                            Years of Bioanalysis Services in Industry Leading Time

                                                            450+

                                                            Custom Bioanalytical Methods Completed Within Budget

                                                            Expected Services Turnaround

                                                            We wholeheartedly cooperate with your team to accomplish our shared goals and accelerate your PK study timeline. For example, we need just four to six weeks for PK assay development and validation at our pharmacokinetics lab. Afterward, we need a couple of weeks for submitting your audited report with complete details of validation experiments. Here, we pull together our core strengths – scientific experience, regulatory expertise, and operational excellence – to make sure your resources and costs are optimized.

                                                            Requested Sponsor Input

                                                            Our team thrives on open lines of communication between sponsors and our frontline scientists, project managers, PK lab staff, etc. Could you please share additional details about your analyte(s), preferred critical reagents and assay supplies, current bioanalytical method(s), data from previous run(s), study protocols (with # of cohorts, samples), etc to expedite outlining the scope of work for quotation and timeline estimation?

                                                            Reviews From Sponsors of Our Pharmacokinetics Services

                                                            Sponsor
                                                            Executive Director, Pharmacokinetics

                                                            We trust NorthEast BioLab to design and execute streamlined, impactful bioanalytical projects

                                                            Sponsor
                                                            VP, PK PD Analysis

                                                            NorthEast BioLab always exceeds expectations on bioanalytical assay development, validation, and sample analysis.

                                                            Sponsor
                                                            Sr. Associate Dir., Clinical Trials

                                                            We have worked with NorthEast BioLab for over ten years given their commitment to highest quality bioanalytical data.

                                                            Sponsor
                                                            Head, PK

                                                            This study, same as all other bioanalytical studies, was completed with top quality and reporting standard with incredible responsiveness.

                                                            Sponsor
                                                            Director, PK

                                                            We worked closely to implement the most efficient and cost-effective bioanalytical assay for our PK Studies.

                                                            Sponsor
                                                            Sr. Dir., Bioanalytical Development & QC

                                                            NorthEast BioLab offers a science-based, hands-on approach to the latest bioanalytical platforms

                                                            Contact A Scientist With Your Pharmacokinetic Study Details

                                                            We Will Respond Within 1 Business Day

                                                            forms-banner

                                                            Premier Pharmacokinetic Study Assay Laboratory Services At Your Terms To Efficiently Accelerate Your Drug Programs

                                                            Responsive Pharmacokinetics Assay Services

                                                            • Fast and flexible PK assay services with transparent communication and feedback.
                                                            • Direct collaboration with senior scientists to troubleshoot and improve PK trial outcomes.
                                                            • Consistent program quality with a dedicated focus on PK assay and sample analysis.

                                                            Expert Pharmacokinetic and ADA Assay Services

                                                            • Extensive PK and ADA assay experience to optimize clinical trial analysis.
                                                            • A thorough review of methods, data, and regulatory needs to streamline PK analysis.
                                                            • Over 30 years of regulatory expertise in the life sciences community.
                                                            Bioanalytical Lab Services

                                                            Introduction To Pharmacokinetics

                                                            Pharmacokinetics (PK) is the analysis and description of the disposition of a drug in the body, encompassing the development of the mathematical description of all dispositional processes in the body, defined as ADME – absorption, distribution, metabolism, and elimination…

                                                            PK Video
                                                            Read More

                                                            Our Streamlined Process For On-Time Delivery Of Entire Scope Of Work Within Sponsor Budget

                                                            Customer Inquiry Icon customer
                                                            Inquiry
                                                            arrow
                                                            Customer Inquiry Icon Fit
                                                            Evaluation
                                                            arrow
                                                            Customer Inquiry Icon Preliminary
                                                            Consulting
                                                            arrow
                                                            Customer Inquiry Icon Quotation
                                                            Request
                                                            arrow
                                                            Customer Inquiry Icon Project
                                                            Initiation
                                                            NorthEast Biolab Logo
                                                            Method Development Icon Method
                                                            Development
                                                            arrow
                                                            Method Development Icon Method
                                                            Validation
                                                            arrow
                                                            Method Development Icon Sample
                                                            Measurement
                                                            arrow
                                                            Method Development Icon Pharmacokinetic
                                                            Studies
                                                            arrow
                                                            Method Development Icon Audited
                                                            Report
                                                            arrow
                                                            Method Development Icon Next
                                                            Steps

                                                            Why Choose Us For Your Pharmacokinetics Study?

                                                            Independent Pharmacokinetics Assay, Pharmacokinetics Studies and Pharmacokinetic CRO Trusted By Biotech Over 20+ Years!

                                                            Contact A Scientist With Your Pharmacokinetic Study Details

                                                            We Will Respond Within 1 Business Day

                                                            • PK Assay Development, GLP Validation, and PK PD Analysis At Industry-Leading Turnaround by our Pharmacokinetics Lab
                                                            • Tailor-Made, High-Value PK ELISA And PK LC-MS Assay Services For Biotech
                                                            • Comprehensive PK ADA Assay Services For Immunogenicity And PK Samples in PK Clinical Trial
                                                            • PK Blood Sample Analysis For Small Molecules, Peptides, Biologics, Nucleic Acids, etc
                                                            • Good Laboratory Practice for Nonclinical Laboratory Studies | NorthEast BioLab
                                                            • Food and Drug Administration (FDA | NorthEast BioLab
                                                            • Clinical Laboratory Improvement Amendments | NorthEast BioLab
                                                            • International Orgaization for Standardization |NorthEast BioLab
                                                            • United States Drug Enforcement Administration | NorthEast BioLab
                                                            • Department of Consumer Protection | NorthEast BioLab

                                                            Support Your Drug Innovation With Latest Equipment In Safe Hands Of Our Bioanalysis Experts for Pharmacokinetics Clinical Trials

                                                            We judiciously invest in our people, solutions and infrastructure, and regularly review our business processes and practices to exceed sponsor expectations

                                                            Liquid Chromatography Mass Spectrometry

                                                            ELISA Assay

                                                            Meso Scale Discovery Assay

                                                            qPCR Analysis, ddPCR Assay

                                                            Related FAQs

                                                            Answers To Additional Pharmacokinetics Studies Questions Popular Among Our Potential Sponsors.

                                                            What is a Pharmacokinetic (PK) Study?

                                                            A pharmacokinetic study provides the basis for determining drug exposures in the body over time. PK parameters are used in the evaluation of the absorption, distribution, metabolism, and excretion (ADME) processes of drugs.

                                                            In simpler terms, a pharmacokinetics study focuses on understanding the effect a body has on the administered drug product. By exploring individual ADME components, pharmacokinetics labs help clinicians prescribe the correct doses that will generate the highest benefit but with the least associated risk factors. Besides, pharmacokinetic studies aid in adjusting the drug doses depending on individual physiology and lifestyle. Hence, PK sample analysis is crucial for the success of a drug development project. From drug discovery and preclinical studies to PK clinical trials, pharmacokinetics assays are employed at every stage of drug development. Let us explore the importance of PK in clinical research through ADME studies.

                                                            Absorption

                                                            Absorption brings an administered drug product into the systemic circulation. Absorption affects the concentration and speed at which a drug reaches its target location. Clinical pharmacokinetic services employ different administration methods to generate clinical trial PK data. These routes of administration include oral, intramuscular, intravenous, subcutaneous, intrathecal, rectal, buccal, ocular, vaginal, inhaled, otic, transdermal, and nebulized. Each method has its advantages and limitations during PK analysis in pharmacokinetics clinical trials.

                                                            Absorption also includes liberating the active ingredient from the pharmaceutical drug form. Pharmacokinetics in clinical trials focuses on drug liberation, especially for oral medications. For example, the oral medication may reside in the throat or esophagus for an extended period after being ingested. This delay may damage the mucosa and impede the onset of drug effects. Besides, the low pH in the stomach may chemically react with the drugs even before they reach systemic circulation. Therefore, clinical pharmacokinetics services are concerned, particularly with drug absorption and liberation.

                                                            Distribution

                                                            Drug distribution varies from individual to individual. This variation is based on the drug properties and individual physiology. Hence, diffusion and convection are the primary factors affecting PK sample analysis in clinical trials. Moreover, these factors are affected by the size, binding kinetics, and polarity of the drug and the fluid status and body habitus of the patient. The primary aim of distribution in PK trials is to achieve effective drug concentration. For a drug product to be effective and active, it must reach its desired compartmental destination based on the volume of distribution and not protein-bound concentration.

                                                            Metabolism

                                                            Metabolism is the next step in a PK study clinical trial. It is the action of segregating the drug compound into components. Metabolism converts a drug compound into more water-soluble components and progresses them to renal clearance. It also metabolizes a prodrug into its active metabolites. Each body compartment, such as skin, plasma, gastrointestinal tract, lungs, and kidneys, has its metabolism strategy. PK labs and PK CROs focus on phase I and II reactions in the liver, as most of the metabolism occurs in the liver.

                                                            Excretion

                                                            Excretion is the final phase of PK evaluations of PK samples in clinical trials. It is through excretion that a drug is eliminated from the system. Generally, kidneys are common excretory organs. Although, certain drugs can be excreted through the skin, lungs, or gastrointestinal tract. However, pharmacokinetic CROs are always focused on complications associated with the reabsorption of specific compounds. In conclusion, Pharmacokinetics assays are essential in generating ADME data.

                                                            When is PK Analysis performed during Drug Development?

                                                            PK analysis in clinical trials is performed throughout the drug research and development process, starting from early discovery to the last Phase of drug development. The primary purpose of preclinical pharmacokinetic studies is to evaluate the characteristics of potential drugs to predict exposures and determine dose levels and frequencies for testing new chemical entities in preclinical disease efficacy models. PK studies in multiple species can be used to predict human pharmacokinetics and estimate the dose required for clinical efficacy and potential manufacturing costs for the intended drug product after achieving therapeutic proof-of-concept and honing structure-activity-relationships (SAR) to determine lead molecules. Pharmacokinetic (PK) Assays during the preclinical phase help determine bioavailability, the volume of distribution, half-life, and clearance. These PK studies help evaluate if the drug has adequate success potential or needs to be modified to improve its pharmacokinetic parameters. Pharmacokinetic (PK) study results from the preclinical stage help design IND enabling Tox studies in animals, and drugs can be advanced farther into clinical development based on these preclinical results. PK bioanalysis meeting the requirements for first in human (FIH) dosing initially undergo single ascending dose (SAD) clinical trials to assess the safety and clinical pharmacokinetics, followed by later multiple ascending dose (MAD) clinical trials to assess steady-state exposures and to correlate with drug pharmacology.

                                                            What does PK stand for in clinical trials?

                                                            We perform PK analysis in clinical trials to examine the absorption, distribution, metabolism, and excretion of a drug. These studies are useful for determining the appropriate dose range for safety and efficacy in subsequent trials. Pharmacokinetic (PK) testing involves a quantitative analysis of the time course of a drug in the body. PK testing in clinical trials often assesses single ascending doses (SAD studies) to investigate dosage proportionality and multiple ascending doses (MAD studies) to correlate the PK effect changes with repeated dosage. SAD and MAD PK studies in clinical trials provide information regarding metabolic alterations and the achievement of steady-state exposures during chronic therapies. Other PK clinical trials include bioavailability and bioequivalence studies, assessment of drug-drug interaction (DDI) potential, and drug penetration studies depending on the therapeutic target.

                                                            What are the key components evaluated in a pharmacokinetic (PK) study, and how do they relate to the ADME processes of drugs?

                                                            Pharmacokinetic (PK) studies are crucial in understanding how drugs behave in the body over time. These studies evaluate several key components that directly relate to the ADME processes (Absorption, Distribution, Metabolism, and Excretion) of drugs. Here are the primary components evaluated in PK studies and their relation to ADME processes:

                                                            Key Components Evaluated in PK Studies
                                                            1. Absorption
                                                            • C_max (Maximum Concentration): The peak plasma concentration of a drug after administration, indicating the extent and rate of absorption.
                                                            • T_max (Time to Maximum Concentration): The time it takes for the drug to reach C_max, providing insight into the rate of absorption.
                                                            • AUC (Area Under the Curve): Represents the total drug exposure over time, indicating the extent of drug absorption.
                                                            2. Distribution
                                                            • Volume of Distribution (V_d): A theoretical volume that describes how extensively a drug is distributed throughout the body tissues relative to the plasma. It helps in understanding the extent of drug distribution.
                                                            • Plasma Protein Binding: The degree to which a drug binds to plasma proteins, affecting its distribution and free (active) drug concentration.
                                                            3. Metabolism
                                                            • Metabolic Clearance (Cl): The volume of plasma from which the drug is completely removed per unit time due to metabolic processes, primarily in the liver.
                                                            • Metabolite Profile: Identification and quantification of drug metabolites to understand the biotransformation pathways.
                                                            4. Excretion
                                                            • Renal Clearance: The volume of plasma cleared of the drug by the kidneys per unit time, indicating the rate of renal excretion.
                                                            • Half-Life (t_1/2): The time required for the plasma concentration of the drug to reduce by half, reflecting the combined effects of metabolism and excretion.
                                                            • Excretion Rate: The rate at which the drug and its metabolites are eliminated from the body, typically measured in urine or feces.
                                                            Relation to ADME Processes
                                                            • Absorption: Evaluated by C_max, T_max, and AUC. These parameters help in understanding how quickly and efficiently a drug enters the systemic circulation from the site of administration.
                                                            • Distribution: Assessed through volume of distribution and plasma protein binding. These factors determine how the drug is dispersed throughout body fluids and tissues, impacting its therapeutic and side effects.
                                                            • Metabolism: Studied via metabolic clearance and the metabolite profile. Metabolism transforms the drug into metabolites, which can be active or inactive, influencing the drug's efficacy and safety.
                                                            • Excretion: Evaluated through renal clearance, half-life, and excretion rate. These parameters describe how the drug and its metabolites are removed from the body, affecting the duration of the drug’s action and the frequency of dosing.

                                                            Understanding these components in PK studies allows researchers and clinicians to optimize drug dosing regimens, enhance therapeutic efficacy, minimize toxicity, and predict drug-drug interactions.

                                                            What is the main purpose of PK testing?

                                                            In early drug discovery, we often perform PK testing to determine whether new chemical entities (NCEs) have adequate exposures for in-vivo efficacy models in mice. Even before dosing in the animals, we typically perform in-vitro clinical pharmacokinetics services to filter out compounds with high metabolic rates or weak absorption potential. During preclinical development, pharmacokinetic testing in additional species is generally performed in one rodent and one non-rodent species to prepare for toxicology and toxicokinetics studies. Additional clinical pharmacokinetics services include allometry or other scaling models to predict clinical PK from the preclinical data ahead of the pharmacokinetics clinical trials. Early clinical PK studies are often performed at sub efficacious dosage with slow dose escalation to maintain safety and determine the clinical PK parameters while ramping towards therapeutic doses. For reformulations or generics of approved compounds, we perform PK testing to demonstrate bioequivalence. During all drug development phases, PK lab test results may be used to assess dose proportionality, steady-state exposure levels, bioavailability, and the general ADME properties of the test compounds in the various test species.

                                                            How do you perform a pharmacokinetic study?

                                                            Pharmacokinetic (PK) study design follows some basic general principals even as it varies based on the chemical structures of the tested compounds and the intended therapeutic targets. Initially, we dissolve the test compound in an appropriate dosing vehicle. Then, the test species is dosed with the vehicle and blood samples are collected over a pre-specified period for drug concentration analysis. Afterward, we plot the blood draw time vs. concentration curves and calculate the PK parameters such as the area under the curve, maximum concentration, clearance, distribution volume, elimination half-life, etc. We select the species and strains for pharmacokinetic studies in animals to meet our objective towards proving compound efficacy and safety with the ultimate goal of reaching the clinic and marketplace. During drug discovery, PK studies in mice and rats are often performed in tandem with pharmacodynamic studies to achieve in-vivo proof of concept against a disease target. Late phase discovery and development PK studies are performed in multiple species to support preclinical toxicology and regulatory submissions.

                                                            What is the importance of pharmacokinetics analysis in drug development?

                                                            Pharmacokinetic analysis provides direct information about the fate of a test compound in the body. Pharmacokinetics research focuses on the relationship between the dosing regimen and the body’s exposure to the drug. Typically, we generate PK data through non-compartmental analysis. Non-compartmental PK parameters include area under the curve (AUC), maximum exposure (Cmax), clearance (CL or CL/F), distribution volume (Vd or Vd/F), elimination half-life (t½), etc. These parameters provide crucial information about any drug’s absorption and elimination rates, as well as the potential to distribute to tissues throughout the body. Pharmacokinetics in drug development from multiple species can be used to predict dosing levels and regimens for efficacy in animal models of disease, for predictions of doses required for preclinical toxicology studies, and to scale predicted clinical PK parameters and estimate initial clinical doses.

                                                            What are the four major components of pharmacokinetics study?

                                                            Pharmacokinetics assays provide a quantitative description of what a body does to a drug. The four major components of the pharmacokinetics process are absorption, distribution, metabolism, and excretion commonly referred to as ADME. Absorption is the process of getting the drug from the site of delivery into the systemic circulation. For example, orally administered compounds must be soluble in the gut environment, then permeate the gastrointestinal tract and pass through the portal vein and the liver (known as the first pass) before reaching central circulation. Distribution describes the drug’s ability to enter and leave central circulation to reach tissues and organs throughout the body. Metabolism and excretion are the processes of eliminating drugs and xenobiotics from the body via metabolic processes or direct biliary or renal excretion of unchanged drug.

                                                            What is the difference between pharmacokinetics and pharmacodynamics?

                                                            Pharmacodynamics describes what the drug does to the body, and pharmacokinetics describes what the body does to the drug. Pharmacokinetics (PK) and pharmacodynamics (PD) are both components of in-vivo pharmacology. Pharmacokinetics evaluates absorption, distribution, metabolism, and excretion of drugs by the determination of systemic exposure over time. Pharmacodynamics studies the relationship between drug concentration at the site of action (receptor) and the observed pharmacological response. PK describes drug exposure, and PD describes drug effects. PK PD analysis provides the relationship between the drug’s in-vivo exposure and efficacy. PK PD studies in multiple species during drug discovery and development are often useful for predictions of initial dosing levels and regimens for safety and efficacy in the clinic.

                                                            What are pharmacokinetic (PK) parameters?

                                                            In-vivo PK drug assessments are critical in drug discovery, development, and clinical testing. Non-compartmental pharmacokinetic (PK) drug parameters vary depending on study design, but typically include volume of distribution (Vd) and total plasma clearance (CL) following IV doses, time to maximum concentration (Tmax), maximum observed concentration (Cmax), area under plasma concentration vs. time curve (AUC), elimination half-life (t1/2) for all dose routes, and bioavailability (F%) where extravascular and IV routes have been tested. As appropriate, our team of experienced scientists at NorthEast BioLab can aid you in study and protocol design, study monitoring, sample bioanalysis, pharmacokinetics parameter calculation using validated Phoenix WinNonlin software, and result interpretation during all project phases.

                                                            Explore More Services

                                                            • Reliable Pharmacokinetics Services CRO And PK Assay Lab | NorthEast BioLab Pharmacokinetics (PK)
                                                              Study
                                                            • ADA Assay | NorthEast BioLab ADA Assay, Neutralizing Antibody Assay
                                                            • Cytokine-Assay Multiplex Cytokine Assay
                                                            • Multiplex Cytokine Analysis And Biomarker Assay | NorthEast BioLab Biomarker Assay
                                                            • Cell-Based Assay | NorthEast BioLab Cell-Based
                                                              Assay
                                                            • Bioanalytical Assay Development Lab | NorthEast BioLab Bioanalytical
                                                              Assay Validation

                                                            Contact A Scientist With Your Bioanalytical Study Details

                                                            We Will Respond Within 1 Business Day

                                                            Expertise

                                                            Expertise

                                                            • Mass Spectrometry (LC-MS)
                                                            • Meso Scale Discovery Assay
                                                            • ELISA Assay
                                                            • Flow Cytometry
                                                            • qPCR Analysis, ddPCR Assay
                                                            • Western Blot, In Cell Western

                                                            Services

                                                            Services

                                                            • Pharmacokinetics (PK) Study
                                                            • ADA Assay, Neutralizing Antibody Assay
                                                            • Multiplex Cytokine Assay
                                                            • Biomarker Assay
                                                            • Cell-Based Assay
                                                            • Bioanalytical Assay Validation

                                                            Solutions

                                                            Solutions

                                                            • Clinical CRO
                                                            • GLP Laboratory
                                                            • Preclinical CRO
                                                            • Method Development, Validation, And Transfer
                                                            • Analytical Testing

                                                            About Us

                                                            About Us

                                                            • Overview
                                                            • Leadership
                                                            • Facility and Equipment
                                                            • Quality and Compliance
                                                            • Therapeutic Areas
                                                            • Why Us?
                                                            • Values
                                                            • Process
                                                            • Partners
                                                            • Careers

                                                            Resources

                                                            Resources

                                                            • Learning Center
                                                            • Blog
                                                            • Case Study
                                                            • Video Brochures
                                                            • News and Events
                                                            • Testimonials
                                                            • Contact Us
                                                            NorthEast BioLab Logo Agile Bioanalytical Services CRO
                                                            sales@nebiolab.comFollow Up On Email
                                                            (203) 361 3780Follow Up On Phone

                                                            35 Worth Ave, Hamden, CT 06518

                                                            • Good Laboratory Practice for Nonclinical Laboratory Studies | NorthEast BioLab
                                                            • Food and Drug Administration (FDA | NorthEast BioLab
                                                            • clia
                                                            • United States Drug Enforcement Administration | NorthEast BioLab
                                                            • Department of Consumer Protection | NorthEast BioLab
                                                            • Privacy Policy
                                                            • Terms of Use
                                                            • Sitemap
                                                            All rights reserved.